Shanghai Pharma Buys U.S. Cardinal Health ' s China Business Shanghai Pharma Buys U.S. Cardinal Health ' s China Business
Shanghai Pharmaceuticals Holding Co has agreed to buy Cardinal Health Inc ' s China drug distribution business for $557 million, winning a highly competitive auction in a move that will greatly expand its presence nationwide.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news